Literature DB >> 31392132

Biomarkers for platinum sensitivity in bladder cancer: are we there yet?

Nirmish Singla1, Rashed A Ghandour1, Ganesh V Raj1.   

Abstract

Entities:  

Year:  2019        PMID： 31392132      PMCID： PMC6642961          DOI： 10.21037/tau.2019.01.10

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  27 in total

Review 1.  Genome maintenance mechanisms for preventing cancer.

Authors:  J H Hoeijmakers
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications.

Authors:  Aliya Qayyum
Journal:  Radiographics       Date:  2009-10       Impact factor: 5.333

3.  Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

Authors:  Woonyoung Choi; Sima Porten; Seungchan Kim; Daniel Willis; Elizabeth R Plimack; Jean Hoffman-Censits; Beat Roth; Tiewei Cheng; Mai Tran; I-Ling Lee; Jonathan Melquist; Jolanta Bondaruk; Tadeusz Majewski; Shizhen Zhang; Shanna Pretzsch; Keith Baggerly; Arlene Siefker-Radtke; Bogdan Czerniak; Colin P N Dinney; David J McConkey
Journal:  Cancer Cell       Date:  2014-02-10       Impact factor: 31.743

4.  Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis.

Authors:  John L Gore; Julie Lai; Claude M Setodji; Mark S Litwin; Christopher S Saigal
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

5.  Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy.

Authors:  Guru Sonpavde; Bryan H Goldman; V O Speights; Seth P Lerner; David P Wood; Nicholas J Vogelzang; Donald L Trump; Ronald B Natale; H Barton Grossman; E David Crawford
Journal:  Cancer       Date:  2009-09-15       Impact factor: 6.860

6.  Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study.

Authors:  Siamak Daneshmand; Hamed Ahmadi; Ly N Huynh; Nora Dobos
Journal:  Urology       Date:  2012-10-04       Impact factor: 2.649

7.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Authors:  H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood; Derek Raghavan; E David Crawford
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

Review 8.  Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis.

Authors:  Fausto Petrelli; Andrea Coinu; Mary Cabiddu; Mara Ghilardi; Ivano Vavassori; Sandro Barni
Journal:  Eur Urol       Date:  2013-07-03       Impact factor: 20.096

9.  Outcome after radical cystectomy in patients with clinical T2 bladder cancer in whom neoadjuvant chemotherapy has failed.

Authors:  Murugesan Manoharan; Devendar Katkoori; Thekke A Kishore; Bruce Kava; Rakesh Singal; Mark S Soloway
Journal:  BJU Int       Date:  2009-05-19       Impact factor: 5.588

10.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Authors:  Hannah Farmer; Nuala McCabe; Christopher J Lord; Andrew N J Tutt; Damian A Johnson; Tobias B Richardson; Manuela Santarosa; Krystyna J Dillon; Ian Hickson; Charlotte Knights; Niall M B Martin; Stephen P Jackson; Graeme C M Smith; Alan Ashworth
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504
View more
  1 in total

1.  Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.

Authors:  Jiao Hu; Anze Yu; Belaydi Othmane; Dongxu Qiu; Huihuang Li; Chao Li; Peihua Liu; Wenbiao Ren; Minfeng Chen; Guanghui Gong; Xi Guo; Huihui Zhang; Jinbo Chen; Xiongbing Zu
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.